Gynecologic Oncology Handbook

Known as the “blue book”, the Gynecologic Oncology Handbook: An Evidence-Based Clinical Guide is an invaluable resource for fellows, residents, and clinicians in the diagnosis and management of gynecologic cancers. Retaining the format and features that have made it a leading practical reference, this new edition has been thoroughly updated and reflects the latest advances in surgical techniques, chemotherapy protocols, breakthroughs in immunotherapies and targeted therapies, and much more.

The handbook covers the full scope of disease management in a concise and accessible format. Its compact size allows it to be easily taken with the busy practitioner on the ward or in the clinic. Clear illustrations that reinforce key concepts and essential algorithms for diagnostic techniques help clinicians to a quick and accurate diagnosis. Evidence-based practices for managing gynecologic cancers are emphasized throughout the handbook including for surgical care, and for all adjuvant therapies including chemotherapy, biologics, targeted therapies, immunotherapies, and combination radiation therapy. Detailed sections on survivorship care, palliative care, and management of reproductive function and other comorbid medical conditions round out the book’s comprehensive scope.

Its extensive coverage of current breakthroughs in treatment, references to critical clinical studies, and breakdown of directed gynecologic cancer workups and treatments make the Gynecologic Oncology Handbook, 3rd Edition a go-to resource within the field—including in preparation for the gynecologic oncology subspecialty certification oral board exam.

Key Features:

• Covers all fundamentals of gynecologic oncology including workup, AJCC and FIGO staging, surgical management, chemotherapy, targeted therapy, immunotherapy, and radiation therapy treatment, comorbidity diagnosis and management, and background study data
• Contains insight into recently approved immunotherapies for recurrent advanced and metastatic cervical and uterine disease
• Provides Gynecologic Oncology Referral Parameters, Performance Status Scales, Adverse Event Grading, RECIST evaluation criteria, chemotherapy protocols, statistics, and other useful formulas
• Includes clinical study references, medical comorbidity algorithms, directed workups, and treatment guidelines

List of Tables

List of Figures

Preface

1. CANCER SCREENING, PREVENTION, AND PREINVASIVE GYNECOLOGIC DISEASE

Cervical Cancer Screening

Preinvasive Disease

Tubo-Ovarian Cancer Screening

2. GYNECOLOGIC CANCERS

Cervical Cancer

Tubo-Ovarian Cancers: Ovarian, Fallopian Tube, and Primary Peritoneal

Epithelial Tubo-Ovarian Cancer

Ovarian Tumors of Low Malignant Potential (LMP): Borderline Tumors

Fallopian Tube Cancer

Primary Peritoneal Cancer

Germ Cell Tumors

Sex Cord Stromal Tumors

Uterine Cancer

Vulvar Cancer

Vaginal Cancer

Gestational Trophoblastic Disease

3. HEREDITARY CANCER SYNDROMES

Hereditary Breast and Ovarian Cancers

4. SURGICAL CARE FOR GYNECOLOGIC CANCERS

Anatomy

Preoperative Risk Assessment and Optimization

Surgical Procedures

Surgical Devices

Intraoperative Complications

Postoperative Care Protocols

Postoperative Complications

Perioperative Management of Medical Comorbidities

Critical Care

5. GYNECOLOGIC CANCER SYSTEMIC TREATMENT MODALITIES

Chemotherapy

Classes of Chemotherapy Agents and Independent Mechanisms of Action (Cytotoxic, Targeted, Immunologic)

Radiation Therapy

6. REPRODUCTIVE FUNCTION, SEXUALITY, AND GYNECOLOGIC CANCER

Sexual Function, Fertility, and Cancer

Cancer in Pregnancy

7. SURVIVORSHIP CARE FOR GYNECOLOGIC MALIGNANCIES

Surveillance Recommendations

8. PALLIATIVE CARE

Palliative Care Pathways

Delivering Bad News

9. STATISTICS AND REFERENCE MATERIAL

Statistics

Reference Material

Gynecologic Oncology Referral Parameters

Performance Status Scales

Adverse Event Grading

Abbreviations

Index